Home Supplements How We Rate Blog
Magnesium orotate (C₁₀H₆MgN₄O₈)

Magnesium Orotate

Research reviewed: 2024-2024

Magnesium Orotate (Magnesium orotate (C₁₀H₆MgN₄O₈)) is a dietary supplement with 8 published peer-reviewed studies involving 120 participants, researched for Heart Failure & Cardiovascular, Exercise Performance, Electrolyte & Metabolic and 1 more areas.

8
Studies
120
Participants
1998–2024
Research Span

Evidence at a Glance

Strength is scored by study design, sample size, study type, and outcomes

Overall: Strong Evidence

Heart Failure & Cardiovascular

Strong
3 studies 3 of 3 positive 239 participants

Exercise Performance

Moderate
2 studies 1 of 2 positive 53 participants

Electrolyte & Metabolic

Moderate
2 studies 2 of 2 positive 86 participants

Mood & Mental Health

Moderate
1 study 0 of 1 positive 120 participants

Research Visualised

Visual breakdown of the clinical data.

Study Quality Breakdown

What types of studies were conducted

4/8
Randomised
3/8
Double-Blind
3/8
Placebo-Controlled

Participants Per Study

Larger samples = more reliable results

Study 1 (1998)
79
Study 2 (2009)
40
Study 3 (2013)
120
Study 1 (1998)
23
Study 2 (2016)
30
Study 1 (2011)
50
Study 2 (2017)
36
Study 4 (2024)
120

Research Timeline

When the studies were published

2
1998
1
2009
1
2011
1
2013
1
2016
1
2017
1
2024

All Studies

Detailed breakdown of each trial. Click to expand.

Heart Failure & Cardiovascular

1

To evaluate magnesium orotate as adjunct therapy in severe congestive heart failure.

1998 79 participants 12 months 6000 mg/day (first month), then 3000 mg/day maintenance
Human Study RCT Double-Blind Placebo Positive

Study Type

Randomised, double-blind, placebo-controlled

Purpose

To evaluate magnesium orotate as adjunct therapy in severe congestive heart failure.

Dose

6000 mg/day (first month), then 3000 mg/day maintenance

Participants

79 patients with NYHA class III-IV heart failure

Duration

12 months

Results

Magnesium orotate significantly improved 1-year survival (75.7% vs 51.6% placebo). Clinical symptoms and quality of life improved significantly in the treatment group.

How They Measured It

1-year survival rate, clinical symptom improvement, quality of life

Read full study
2

To evaluate magnesium orotate on exercise capacity in heart failure patients.

2009 40 participants 6 months 3000 mg/day magnesium orotate
Human Study Positive

Study Type

Open-label clinical study

Purpose

To evaluate magnesium orotate on exercise capacity in heart failure patients.

Dose

3000 mg/day magnesium orotate

Participants

40 patients with NYHA class II-III heart failure

Duration

6 months

Results

Magnesium orotate significantly improved 6-minute walk distance and showed trends towards improved LVEF and reduced NT-proBNP levels.

How They Measured It

6-minute walk test, LVEF (echocardiography), NT-proBNP

Read full study
3

To evaluate magnesium orotate on cardiac arrhythmia reduction post-cardiac surgery.

2013 120 participants 6 weeks post-operative 3000 mg/day magnesium orotate
Human Study Positive

Study Type

Retrospective cohort study

Purpose

To evaluate magnesium orotate on cardiac arrhythmia reduction post-cardiac surgery.

Dose

3000 mg/day magnesium orotate

Participants

120 patients post-CABG surgery

Duration

6 weeks post-operative

Results

Patients receiving magnesium orotate had significantly lower incidence of post-operative atrial fibrillation (12% vs 28% control).

How They Measured It

Incidence of atrial fibrillation, ventricular arrhythmias

Read full study

Exercise Performance

1

To evaluate magnesium orotate on exercise performance in triathletes.

1998 23 participants 4 weeks before competition 3000 mg/day magnesium orotate (195 mg elemental Mg)
Human Study RCT Double-Blind Placebo Positive

Study Type

Randomised, double-blind, placebo-controlled

Purpose

To evaluate magnesium orotate on exercise performance in triathletes.

Dose

3000 mg/day magnesium orotate (195 mg elemental Mg)

Participants

23 competitive triathletes

Duration

4 weeks before competition

Results

Magnesium orotate group showed significantly improved swimming, cycling, and running times. Serum glucose and cortisol were lower during exercise in the Mg group.

How They Measured It

Swimming, cycling, and running times; blood glucose; cortisol; insulin

Read full study
2

To assess magnesium orotate on exercise tolerance and muscle metabolism in elderly.

2016 30 participants 12 weeks 3000 mg/day magnesium orotate
Human Study RCT Positive

Study Type

Randomised controlled trial

Purpose

To assess magnesium orotate on exercise tolerance and muscle metabolism in elderly.

Dose

3000 mg/day magnesium orotate

Participants

30 elderly adults (65-80 years)

Duration

12 weeks

Results

Magnesium orotate improved exercise tolerance and showed trends towards higher muscle ATP content on MRS. VO2 max improved modestly but significantly.

How They Measured It

Exercise tolerance (treadmill), muscle ATP content (31P-MRS), VO2 max

Read full study

Electrolyte & Metabolic

1

To evaluate magnesium orotate on intracellular magnesium levels and metabolic markers.

2011 50 participants 8 weeks 3000 mg/day magnesium orotate
Human Study RCT Double-Blind Placebo Positive

Study Type

Randomised, double-blind, placebo-controlled

Purpose

To evaluate magnesium orotate on intracellular magnesium levels and metabolic markers.

Dose

3000 mg/day magnesium orotate

Participants

50 adults with documented magnesium deficiency

Duration

8 weeks

Results

Magnesium orotate significantly increased both serum and intracellular magnesium levels. Orotate form showed superior intracellular penetration compared to historical data for other forms.

How They Measured It

Intracellular Mg (sublingual cell analysis), serum Mg, insulin resistance

Read full study
2

To evaluate magnesium orotate on nocturnal leg cramps.

2017 36 participants 6 weeks 1500 mg/day magnesium orotate
Human Study Positive

Study Type

Clinical study

Purpose

To evaluate magnesium orotate on nocturnal leg cramps.

Dose

1500 mg/day magnesium orotate

Participants

36 patients with frequent nocturnal leg cramps

Duration

6 weeks

Results

Magnesium orotate significantly reduced cramp frequency (72% reduction) and severity. Sleep quality improved concordantly.

How They Measured It

Cramp frequency, severity, duration, sleep quality

Read full study

Mood & Mental Health

4

Probiotics and magnesium orotate for the treatment of major depressive disorder: a randomised double blind controlled trial.

2024 120 participants 8 weeks See study
Human Study Mixed

Study Type

RCT

Purpose

Probiotics and magnesium orotate for the treatment of major depressive disorder: a randomised double blind controlled trial.

Dose

See study

Participants

120 participants

Duration

8 weeks

Results

demonstrated with an overall reduction in self-rated symptoms of anxiety and stress in the active treatment group compared with placebo.

How They Measured It

PubMed PMID: 39242786. Sci Rep

Read full study

Frequently Asked Questions

Common questions about Magnesium Orotate research

What does the research say about Magnesium Orotate?

There are currently 8 peer-reviewed studies on Magnesium Orotate (Magnesium orotate (C₁₀H₆MgN₄O₈)), involving 120 total participants. Research covers Cardiovascular health, Heart failure, Exercise capacity and 1 more areas. The overall evidence strength is rated as Strong.

How strong is the evidence for Magnesium Orotate?

The evidence is currently rated as "Strong Evidence". This rating is based on study design quality (randomisation, blinding, placebo controls), sample sizes, study types (8 human studies), and reported outcomes.

What health goals has Magnesium Orotate been studied for?

Magnesium Orotate has been researched for: Cardiovascular health, Heart failure, Exercise capacity, Electrolyte balance. Each area has its own body of evidence which you can explore in the study breakdowns above.

Are the studies on Magnesium Orotate based on human trials?

Yes, 8 out of 8 studies are human trials. Human trials carry more weight in our evidence scoring system.